Reference
Ryan CE, et al. Pneumocystis jirovecii pneumonia and institutional prophylaxis practices in CLL patients treated with BTK inhibitors. Blood Advances 4: 1458-1463, No. 7, Apr 2020. Available from: URL: http://doi.org/10.1182/bloodadvances.2020001678
Rights and permissions
About this article
Cite this article
Multiple drugs. Reactions Weekly 1806, 198 (2020). https://doi.org/10.1007/s40278-020-79216-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-020-79216-6